Erika Udovic - uventia

Erika Udovic

Erika Udovic

Erika Udovic

Senior Principal Scientist

Novartis

Erika Udovic is currently working as a Senior Principal Scientist at Novartis, with experience in human health hazard and safety evaluations of pharmaceutical impurities, including extractables and leachables. Her main responsibilities include providing scientific, toxicological, and regulatory support to ensure appropriate risk management. She conducts safety assessments for various administration routes, using computational and read-across methodologies as needed. Erika is a member in internal cross-functional teams and committees, as well as external consortiums such as the Safety Working Group within ELSIE. Previously, she worked as an occupational toxicologist, compiling risk assessment reports for drug substances, intermediates, and raw materials for worker and patient safety purposes. Erika has a background in Veterinary Medicine and found her passion in Toxicology.

SPEAKED ABOUT:
February 27, 2025
Participate in our event to learn about the latest methods for testing and analyzing Extractables and Leachables.
Upcoming

DAY 1: February 27th, 2025

SESSION: Safety assessment of E&Ls: toxicology assessment workflow and challenges with different administration routes

◆  Introduction to general safety and regulatory considerations for extractables/leachables (E&Ls) in pharmaceutical products.

◆  Considerations for different administration routes, including (topical) ocular.

4th Annual Extractables & Leachables
March 7, 2024
What is next in testing and analyzing for extractables and leachables in biopharmaceutical development and release? Recording of 2 days event sessions [18 video sessions].
Expired

DAY 2: March 8th, 2024

SESSION: Safety assessment of E&Ls: challenges with different administration routes

◆  Introduction to general safety and regulatory considerations for extractables/ leachables (E&Ls) in pharmaceutical products.

◆  Considerations for ocular administration routes.

◆  Assessment strategies for intrathecal (IT) route of administration (tentative at this stage, might be adjusted later).

Speaker Details
  • Profession
    Senior Principal Scientist
  • Company
    Novartis Pharma AG
  • Address
    Basel, Switzerland
Speaker Details
  • Profession
    Senior Principal Scientist
  • Company
    Novartis Pharma AG
  • Address
    Basel, Switzerland